Treatment of Leg Telangiectasias With Nd:YAG 1064nm

Not Applicable

• Conditions: Telangiectasias
• Interventions: Other: Sclerotherapy

• Registration Number: NCT01118390
• Lead Sponsor: Grupo de Cirurgia Vascular

Brief Summary

Studying the results of treatment of dilated vessels of the lower limbs with laser, and compare them to those obtained with sclerotherapy.

Detailed Description

Not available

Study Timeline

• Status Verified: 2009-08
• Study Start: 2009-08
• Primary Completion: 2010-03
• Study First Submitted: 2010-04-29
• Study First Submitted QC: 2010-05-05
• Last Update Submitted: 2010-05-05
• Study First Posted: 2010-05-06
• Last Update Posted: 2010-05-06
• Study Completion: 2010-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• Patients with leg telangiectasias

Exclusion Criteria

• Arterial disease
• Varices
• Diabetes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Sclerotherapy	Sclerotherapy	Patients with leg telangiectasias are treated with 3 sessions of sclerotherapy, with 14 days interval

Primary Outcome Measures

Name	Time	Method
treatment of leg telangiectasias	first day	Patients respond after treatment a questionnaire about satisfaction for both the laser and for conventional sclerotherapy.
Treatment of telangiectasias	1 month	Patients respond after treatment a questionnaire about satisfaction for both the laser and for conventional sclerotherapy.

Secondary Outcome Measures

Name	Time	Method
Presence of adverse effects	after 1 month	Patients are monitored to adverse effects such as blemishes, scars and ulcers
Pain Scores on the Visual Analog Scale	After 1 month	Patients evaluate pain on the Visual Analog Scale

Trial Locations

Locations (1)

Hospital das Clinicas da FMUSP; 🇧🇷 Sao Paulo, Brazil